Hypoglycemic and hypolipidemic effects of Bersama engleriana leaves in nicotinamide/streptozotocin-induced type 2 diabetic rats
© Watcho et al.; licensee BioMed Central Ltd. 2012
Received: 27 May 2012
Accepted: 21 December 2012
Published: 26 December 2012
The present investigation was aimed at evaluating the hypoglycemic and hypolipidemic properties of the aqueous and methanolic extracts from Bersama engleriana leaves in streptozotocin/nicotinamide (STZ-NA)-induced type 2 diabetic rats.
Animals were orally treated for 4 consecutive weeks with Bersama engleriana extracts at doses of 300 or 600 mg/kg. The anti-diabetic effect was examined by measuring blood glucose (BG) at 0, 1, 14 and 28 days after STZ-NA treatment and, total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C) and triglycerides (TG) levels at sacrifice (day 29). Glibenclamide (0.25 mg/kg) was used for comparison.
STZ-NA-induced diabetic rats showed moderate to significant increases in the levels of BG, TG, TC, LDL-C while body weight, HDL-C levels and relative weights of liver and pancreas were decreased compared to controls (non diabetic rats). Administration of the plant extracts to STZ-NA diabetic rats resulted in a significant decrease in BG, TG, TC and LDL-C and the dose 600 mg/kg of the methanolic extract was the most effective; HDL-C level was markedly increased after four weeks compared to untreated diabetic rats. A dose-dependent increase in the relative weights of the diabetogenic organs was observed in the Bersama engleriana groups. It can be also noticed that the methanolic extract, especially the dose 600 mg/kg (p<0.001), produced more effects than glibenclamide and aqueous extract. Rats treated with glibenclamide (0.25 mg/kg) generally gave lower results compared to groups treated with plant extracts.
Results of the present study showed that Bersama engleriana extracts and especially its methanolic extract possess antidiabetogenic properties and beneficial effects on diabetic hyperlipidemia. All these effects could be due to the bioactive components revealed in the Bersama engleriana extracts such as triterpenes and phenols and which could justify its ethnomedical use.
KeywordsBersama engleriana Diabetes mellitus Hypoglycemic Hypolipidemic Rat
Type 2 diabetes is caused by the failure of beta cells to compensate for insulin resistance. This leads to hyperglycaemia, which can in turn exert deleterious effects on β cells . Evidence for the importance of plant extracts in the management of type 2 diabetes is emerging. Medicinal plants are frequently considered to be less toxic and free from side effects than synthetic ones. Bersama engleriana Gurke (Melianthaceae) is one of such plants; it is a small or medium size tree of 6-9 m, rarely exceeding 25 m in height. It is widespread throughout tropical Africa, preferring higher rainfall or evergreen forests. It is distributed from Senegal to Zaire, and parts of southern Africa; the leaves are used for the treatment of many ailments including diabetes and male impotence .
Previous findings have exhibited a variety of pharmacological potentials including blood glucose lowering concentration in oral glucose tolerance test , aphrodisiac , non-toxic, anti-tumor, antioxidant and antimicrobial  and, ejaculation delaying (unpublished data) activities. The present work was undertaken to investigate the antidiabetic effects of aqueous and methanol extracts from the leaves of Bersama engleriana in a non-obese diabetes model characterized by reduced pancreatic insulin contents and moderate hyperglycemic levels, like those usually occurring in human type 2 diabetes. This model, obtained by the combined administration of nicotinamide (NA) and streptozotocin (STZ) is increasingly used for pharmacological research in diabetes [6–9].
Collection of plant material and extraction
The leaves of Bersama engleriana (Melianthaceae) were collected in the Bamboutos mountains, west region of Cameroon. Botanical identification was carried out at the National Herbarium, Yaoundé, Cameroon (HNC) where a voucher specimen No. 32427/HNC has been deposited. The leaves were shade-dried and reduced to powder.
A total of 400 g of the powder of Bersama engleriana leaves were extracted in 5 l of distilled water for 1 h and boiled for 30 min. The heated decoction was taken and allowed to cool at room temperature (22 ± 2°C). The decoction was filtered and the filtrate was oven dried (45°C). The resulting material was found to weigh 112 g (28% yield, w/w based on the dried starting weight). The working solution was obtained by dissolving 1 g of the residue in a known volume of distilled water and the final volume adjusted to 10 mL.
Ground leaves (600 g) of Bersama engleriana were mace-rated with methanol (3 L; 2 × ) for 72 h to yield, after solvent evaporation under reduced pressure, 16.5 g of brownish extract corresponding to an extraction yield of 14.29% (w/w based on the dried starting weight). The working methanolic extract was obtained by dissolving 1 g of the residue in a known volume of distilled water and the final volume adjusted to 10 mL.
Preliminary phytochemical screening
Qualitative phytochemical evaluation was performed on aqueous and methanolic extracts of the leaves of B. engleriana to determine the presence or not of flavonoids (test of Shinoda), sterols (Libermann Buchard test), phenols (ferric chloride test), alkaloids (Dragendorff test), saponins (saponification test) all these tests were performed as described by .
Adult male Wistar rats weighing 200-300 g were used in this study. The animals were maintained at room temperature (22-23°C) with a reverse natural light-dark cycle in the animal house of the Faculty of Science, University of Dschang, Cameroon. Food and tap water were available ad libitum. The experiments were performed in accordance with the internationally accepted standard ethical guidelines for laboratory animal use and care as described in the European Community guidelines; EEC Directive 86/609/EEC, of the 24th November 1986 .
Induction of diabetes
Nicotinamide (95 mg/kg b.w.) (Sigma, Saint-Louis, MO, USA), dissolved in saline, was injected intraperitoneally 15 min before administration of STZ (60 mg/kg b. w.) (Sigma, Saint-Louis, MO, USA), which was dissolved in buffer citrate (pH 4.5) immediately before use. After 1 week, rats with moderate diabetes having hyperglycemia with blood glucose ≥ 126 mg/dl were used for the study . Blood was collected from the tail vein. Controls received both vehicles.
In the experiment, a total of 42 rats (36 diabetic rats + 6 normal rats) were used. Diabetes was induced in rats, 2 weeks before starting the treatment. The animals were divided into seven groups containing six rats each and distributed as follows:
Group 1, control rats given distilled water (10 ml/kg b.w.); Group 2, diabetic rats given distilled water (10 ml/kg b.w.); Group 3, diabetic rats given glibenclamide (0.25 mg/kg b.w.); Group 4, diabetic rats given aqueous extract of Bersama engleriana (300 mg/kg b.w.); Group 5, diabetic rats given aqueous extract of Bersama engleriana (600 mg/kg b.w.); Group 6, diabetic rats given methanolic extract of Bersama engleriana (300 mg/kg b.w.); Group 7, diabetic rats given methanolic extract of Bersama engleriana (600 mg/kg b.w.). All test substances were administered by gastric gavage for 4 weeks. Glycaemia was measured 0, 1, 2, and 4 weeks after pharmacological treatments. Body weight and relative weights of pancreas and liver were recorded. All the seven groups of rats were killed one day after the last treatment (day 29) by cervical dislocation. Blood was collected for total cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), and triglycerides (TG) estimations using commercial kits from INMESCO (Germany).
Data are expressed in mean ± SEM due to the non homogeneity of groups. The effect of the duration of the treatment (week 0 to week 4) on blood glucose concentration was analyzed using ANOVA Repeated Measures followed by Bonferroni test when necessary. For other parameters, One-way analysis of variance (ANOVA) followed by post-hoc Bonferroni was performed using SPSS for Windows version 12.0. Comparisons with p values < 0.05 were considered to be statistically significant.
Results of the phytochemical screening of Bersama engleriana extracts
Group of compounds
Effects of Bersama engleriana on body weight and relative organ weights
Induction of diabetes (untreated diabetic rats) significantly (p<0.01) decreased the body weight compared to controls.
Effects of Bersama engleriana on body weight, relative weights of liver and pancreas and, lipid profile on nicotinamide/streptozotocin-induced diabetic rats
Relative organ weight (mg/g)
210.06 ± 11.25
251.00 ± 10.57
33.86 ± 01.07
4.11 ± 0.50
98.06 ± 05.54
45.37 ± 03.93
36.15 ± 02.50
82.70 ± 05.81
210.53 ± 12.36
203.00 ± 04.52
11.23 ± 0.70***
1.37 ± 0.08***
153.53 ± 17.82 *
118.8 3± 12.82 *
12.44 ± 03.65 *
96.39 ± 15.83
Diabetic + Glibenclamide (0.25 mg/kg)
217.88 ± 22.06
250.50 ± 10.57
13.46 ± 01.31***
0.96 ± 0.09***
134.77 ± 07.58 *
88.09 ± 11.14*#
20.42 ± 02.84 *
70.60 ± 07.87#
Diabetic + Aqueous extract (300 mg/kg)
250.85 ± 12.06
230.00 ± 06.35
14.56 ± 0.69***
1.23 ± 0.15***
127.97 ± 02.07
89.27 ± 07.67*#
17.60 ± 02.05 *
64.05 ± 09.61*#
Diabetic + Aqueous extract (600 mg/kg)
254.85 ± 15.50
237.33 ± 06.33
15.70 ± 01.59***
1.60 ± 0.21***
130.62 ± 06.57 *
76.12 ± 02.35*##
12.10 ± 01.51 *
79.51 ± 11.64#
Diabetic + Methanolic extract (300 mg/kg)
199.41 ± 06.56
224.00 ± 11.69
15.69 ± 0.55***
2.42 ± 0.21***##
123.32 ± 12.46
89.48 ± 12.69*#
29.96 ± 07.28#
59.56 ± 11.39***#
Diabetic + Methanolic extract (600 mg/kg)
187.98 ± 09.24
223.67 ± 07.57
2.41 ± 0.16***##
100.75 ± 14.74#
59.19 ± 08.39###
32.97 ± 04.37#
56.01 ± 09.70***##
The relative weights of pancreas and liver were also decreased in all diabetic animals when compared to controls. However with regard to diabetic animals, a dose-dependent increase in the relative weights of these vital organs was observed in the Bersama engleriana groups. It can be also noticed that the methanolic extract, especially the dose 600 mg/kg, produced more effects (p<0.001) than glibenclamide and aqueous extract (Table 2).
Effects of Bersama engleriana on blood glucose
Effects of Bersama engleriana on blood glucose in nicotinamide/streptozotocin-induced type 2 diabetic rats
Fasting blood glucose level (mg/dl)
Week of treatment
At the time of grouping
97.80 ± 02.97
69.00 ± 07.40a
75.8 ± 09.05a
81.00 ± 04.25a
62.00 ± 03.45a
97.40 ± 04.54
270.80 ± 81.14a***
244.40 ± 69.28a***
202.60 ± 55.54a*
203.00 ± 46.62a**
Diabetic + Glibenclamide (0.25 mg/kg)
86.40 ± 06.53
227.80 ± 83.62a**
146.40 ± 51.05ad
98.20 ± 09.28bd
94.20 ± 11.20bd
Diabetic + Aqueous extract (300 mg/kg)
95.40 ± 05.08
156.60 ± 20.76#a
121.80 ± 06.80#a
109.60 ± 07.15a
96.60 ± 02.67a
Diabetic + Aqueous extract (600 mg/kg)
91.00 ± 06.47
303.80 ± 41.86a***
183.60 ± 33.96bd
119.00 ± 04.63cd
98.00 ± 07.52c
Diabetic + Methanolic extract (300 mg/kg)
90.20 ± 04.18
181.80 ± 48.41a*
114.00 ± 15.71#a
86.60 ± 07.35#a
83.60 ± 08.18#a
Diabetic + Methanolic extract (600 mg/kg)
90.20 ± 03.38
454.00 ± 10.93a*** ###
288.40 ± 45.75b***
167.60 ± 42.28c
89.40 ± 06.23#c
Effects of Bersama engleriana on lipid profile
The diabetic condition in rats (untreated diabetics) raised TC (36.13%), LDL-C (61.82%) and TG (14.20%) concentrations and lowered HDL-C level (65.59%) (p<0.05) compared to control rats (non diabetic rats). Treatment of nicotinamide/streptozotocin-induced diabetic animals with Bersama engleriana extracts and especially the methanolic extract produced opposite effects evidenced by a decrease (p<0.05) in serum TC (percentage of decrease: 300 mg/kg, 19.68%; 600 mg/kg, 34.38%) and LDL-C (percentage of decrease: 300 mg/kg, 24.70%; 600 mg/kg, 50.19%) and an increase in the HDL-C (percentage of increase: 300 mg/kg, 58.48%; 600 mg/kg, 62.27%) concentration when compared to untreated diabetic. A tendency to a decrease in TG concentrations was also observed with regard to diabetic rats receiving distilled water. In general, glibenclamide produced similar effects.
As above observed, the methanolic extract appeared to be more efficient than the aqueous extract at equal dose and, more potent at high dose (600 mg/kg) than glibenclamide (Table 3).
Association of nicotinamide and streptozotocin is being increasingly used for inducing a diabetes mellitus (DM) similar to human’s type 2 DM [6–9]. In this sequential combination, nicotinamide protects pancreatic beta cells, delaying their disappearance, improves their regeneration and controls blood glucose parameters  whereas streptozotocin has toxic effect resulting in increased formation of free radicals that alter the plasma membrane of β cells and fragmented DNA . The moderate hyperglycemic state (≥126 mg/dl) recorded in rats throughout the present experiment confirms the real diabetic status of the animals used in the present study.
In type 2 diabetic rats treated with Bersama engleriana extracts, a significant decrease (p<0.05) in blood glucose concentrations was observed when compared to respective baseline values (week 0). These results further support the hypoglycemic activity of Bersama engleriana previously reported in sugar overloaded normal rats . It is generally believed that most of the medicinal plants with antidiabetic potentials have been found to contain a variety of substances responsible for the reported activities . Thus, phytochemical tests revealed the presence of triterpenes, steroids, saponins and phenolic compounds in Bersama engleriana extracts. It has been demonstrated that triterpenes and phenols stimulate insulin secretion through their antioxidant activities [16, 17]. Oxidative stress has been shown to play a key role in the causation of diabetes. Streptozotocin produces oxygen radicals in the body, which cause pancreatic injury and could be responsible for increased blood sugar as well as lipid peroxidation. As such, antioxidants may have a role in the alleviation of diabetes . From the results obtained in this work, it could be proposed that Bersama engleriana may enhance the antioxidant defense against reactive oxygen species produced under hyperglycemic condition and this could protect beta-cells against loss, and exhibit antidiabetic activity. The in vitro antioxidant property of Bersama engleriana previously reported by  using extracts from the roots, stem bark, leaves and wood of this medicinal plant could be of great importance in the understanding of this suggested in vivo antioxidant activity of Bersama engleriana. It is a well-established fact that many medicinal plants possess antioxidant potentials which might be helpful under diabetic conditions [19–21]. Results from this work also indicate that the methanolic extract, especially the dose 600 mg/kg, produced more alleviating effects. This observation confirms the fact that methanol extracts of plants are generally known for their high contents in chemical compounds capable of producing biological activities .
With regard to the lowering blood glucose concentrations, it could be proposed that Bersama engleriana may act by (1) stimulating insulin secretion similarly to glibenclamide , (2) triggering progressive regeneration of the damaged β cells after sequential injection of nicotinamide and streptozotocin or (3) potentiating glucose uptake and use by various tissues [17, 24, 25]. The improvements observed in the body weight as well as in the relative weights of the pancreas and liver of diabetic animals after plant extract applications further support these proposed pancreatic and extra-pancreatic mechanisms of action of Bersama engleriana[26–29].
As one of the complications that followed diabetic hyperglycemia is dyslipidemia, the serum lipid profile of rats was evaluated in this study. As expected, untreated diabetic animals showed a significant increase in serum TC, LDL-C and TG concentrations against low levels of HDL-C [27, 30, 31]. This increase in serum lipids is mainly due to the increased fatty acid mobilization from adipose tissue. Since insulin has an inhibitory action on HMG-CoA reductase (3-hydroxy-3-methyl-glutaryl coenzyme A reductase), the key enzyme in cholesterol biosynthesis , insulin deficiency or insulin resistance may therefore be responsible for hyperlipidemia. Treatment of type 2 diabetic rats with Bersama engleriana extracts, especially its methanolic extract (600 mg/kg), reversed although not completely dyslipidemia as evidenced by the significant decrease (p<0.05) in TC, LDL-C and TG coupled to the increase in HDL-C (p <0.05). These alleviating effects clearly denote the antihyperlipidemic potential of Bersama engleriana, and may also account in the improvement of liver weight as above observed. It could also be suggested that this antihyperlipidemic effects of Bersama engleriana pass through a decrease in intestinal cholesterol absorption or a decrease in the biosynthesis of cholesterol specifically by decreasing the activity of HMG-CoA reductase inhibitors .
From this study, we can conclusively state that, Bersama engleriana extract and especially the methanolic extract possesses antidiabetogenic properties and beneficial effects on diabetic hyperlipidemia. All these beneficial effects on this rat model could be due to the bioactive components revealed in the Bersama engleriana extracts such as triterpenes and phenols.
The authors are grateful to the Academy of Sciences for the Developing World (TWAS) for the grant « Ref 07-300 RG/BIO/AF/AC; UNESCO FR: 3240184286 » awarded to Professor Watcho Pierre. The authors are also thankful to Professor Irina Obrosova, Pennington Biomedical Research Center, LSU, Baton Rouge, USA, for the kind gift of streptozotocin.
- Gungor N, Bacha F, Saad R, Janosky J, Arslanian S: Youth type 2 diabetes: Insulin resistance, ß-cell failure, or both?. Diab Care. 2005, 28: 638-644. 10.2337/diacare.28.3.638.View Article
- Iwu MM: Handbook of African Medicinal Plants. 1993, Boca Raton, FL: CRC Press, 435-
- Nyah NG, Watcho P, Nguelefack T, Kamanyi A: Hypoglycaemic activity of the leaves extracts of Bersama engleriana in rats. AJTCAM. 2007, 2: 215-221.
- Watcho P, Mekemdjio A, Nguelefack BT, Kamanyi A: Sexual stimulation effects of the aqueous and methanolic extracts from the leaves of Bersama engleriana in adult male rats. Pharmacologyonline. 2007, 1: 464-476.
- Kuete V, Tsafack MA, Tsaffack M, Penlap Beng V, Etoa FX, Nkengfack AE, Marion Meyer JJ, Namrita L: Antitumor, antioxidant and antimicrobial activities of Bersama engleriana (Melianthaceae). J Ethnopharmacol. 2008, 115: 494-501. 10.1016/j.jep.2007.10.027.View ArticlePubMed
- Matsuyama-Yokono A, Tahara A, Nakano R, Someya Y, Hayakawa M, Shibasaki M: Chronic inhibition of dipeptidyl peptidase-IV with ASP8497 improved the HbA(1c) level, glucose intolerance, and lipid parameter level in streptozotocin-nicotinamide-induced diabetic mice. Naunyn Schmiedebergs Arch Pharmacol. 2009, 379: 191-199. 10.1007/s00210-008-0348-x.View ArticlePubMed
- Tahara A, Matsuyama-Yokono A, Nakano R, Someya Y, Shibasaki M: Effects of antidiabetic drugs on glucose tolerance in streptozotocin-nicotinamide-induced mildly diabetic and streptozotocin-induced severely diabetic mice. Horm Metab Res. 2008, 40: 880-886. 10.1055/s-0028-1087167.View ArticlePubMed
- Novelli M, Bonamassa B, Masini M, Funel N, Canistro D, De Tata V, Martano M, Soleti A, Campani D, Paolini M, Masiello P: Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger. Naunyn Schmiedebergs Arch Pharmacol. 2010, 382: 127-137. 10.1007/s00210-010-0524-7.PubMed CentralView ArticlePubMed
- Ananda Prabu K, Kumarappan CT, Christudas S, Kalaichelvan VK: Effect of Biophytum sensitivum on streptozotocin and nicotinamide-induced diabetic rats. Asian Pacific J Tropical Biomed. 2012, 2: 31-35. 10.1016/S2221-1691(11)60185-8.View Article
- De S, Dey YN, Ghosh AK: Phytochemical investigation and chromatographic evaluation of the different extracts of tuber of Amorphaphallus paeoniifolius (Araceae). Int J Pharmaceu Biomed Res. 2010, 1: 150-157.
- EEC: Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. Official Journal of the European Communities. 1986, L358: 1-29.
- Shirwaikar A, Rajendran K, Barik R: Effect of aqueous bark extract of Garuga pinnata Roxb. in streptozotocin-nicotinamide induced type-II diabetes mellitus. J Ethnopharmacol. 2006, 107: 285-290. 10.1016/j.jep.2006.03.012.View ArticlePubMed
- Hypponen E: Micronutrients and the risk of type 1 diabetes: vitamin D, vitamin E, and nicotinamide. Nutr Rev. 2004, 62: 340-347.View ArticlePubMed
- Bedoya FJ, Solano F, Lucas M: N-monomethyl-arginine and nicotinamide prevent streptozotocin-induced double strand DNA break formation in pancreatic rat islets. Experientia. 1996, 52: 344-347. 10.1007/BF01919538.View ArticlePubMed
- Loew D, Kaszkin M: Approaching the problem of bioequivalence of herbal medicinal products. Phytother Res. 2002, 16: 705-711. 10.1002/ptr.1248.View ArticlePubMed
- Jang YY, Song JH, Shin YK, Han ES, Lee CS: Protective effect of boldine on oxidative mitochondrial damage in STZ-induced diabetic rats. Pharm Res. 2000, 42: 361-371. 10.1006/phrs.2000.0705.View Article
- Sarkhail P, Rahmanipour S, Fadyevatan S, Mohammadirad A, Dehghan G, Amin G, Shafiee A, Abdollahi M: Antidiabetic effect of Phlomis anisodonta: Effects on hepatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Pharm Res. 2007, 56: 261-266. 10.1016/j.phrs.2007.07.003.View Article
- Wolff SP: Diabetes mellitus and free radicals. Br Med Bull. 1993, 49: 642-652.PubMed
- Ali Hussain HE: Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma longa, Linn, and partially purified product from Abroma augusta, Linn. in streptozotocin induced diabetes. Indian J Clin Biochem. 2002, 17: 33-43. 10.1007/BF02867969.PubMed CentralView ArticlePubMed
- Leelavinothan P, Muniappan L: Protective role of Scoparia dulcis plant extract on brain antioxidant status and lipid peroxidation in STZ diabetic male Wistar rats. BMC Complement Altern Med. 2004, 4: 16-10.1186/1472-6882-4-16.View Article
- Nain P, Saini V, Sharma S, Nain J: Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol. 2012, 142: 65-71. 10.1016/j.jep.2012.04.014.View ArticlePubMed
- Ojewole JA: Hypoglycemic effect of Sclerocarya birrea [(A. Rich.) Hochst.] [Anacardiaceae] stem-bark aqueous extract in rats. Phytomedicine. 2003, 10: 675-681. 10.1078/0944-7113-00295.View ArticlePubMed
- Pari L, Latha M: Antidiabetic effect of Scoparia dulcis: effect on lipid peroxidation in streptozotocin diabetes. Gen Physiol Biophys. 2005, 24: 13-26.View ArticlePubMed
- Li WL, Zheng HC, Bukuru J, De Kimpeb N: Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004, 92: 1-21. 10.1016/j.jep.2003.12.031.View ArticlePubMed
- Saravanan R, Pari L: Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan-induced hyperglycemic rats. BMC Complement Altern Med. 2005, 5: 1-8. 10.1186/1472-6882-5-1.View Article
- Kamalakkannan N, Mainzen SPP: The effect of Aegle marmelos fruit extract in streptozotocin diabetes – a histopathological study. J Herb Pharmcother. 2005, 5: 87-96. 10.1080/J157v05n03_08.View Article
- Musabayane CT, Mahlalela N, Shode FO, Ojewole JA: Effects of Syzygium cordatum (Hochst) (Myrtaceae) leaf extract on plasma glucose and hepatic glycogen in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2005, 97: 485-490. 10.1016/j.jep.2004.12.005.View ArticlePubMed
- Dzeufiet PD, Ohandja DY, Tedong L, Asongalem EA, Dimo T, Sokeng SD, Kamtchouing P: Antidiabetic effect of Ceiba pentandra extract on streptozotocin-induced non-insulin-dependent diabetic (NIDDM) rats. AJTCAM. 2007, 4: 47-54.PubMed Central
- Fatima SS, Rajasekhar MD, Kumar KV, Kumar MTS, Babu KR, Rao CA: Antidiabetic and antihyperlipidemic activity of ethyl acetate: Isopropanol (1:1) fraction of Vernonia anthelmintica seeds in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2010, 48: 495-501. 10.1016/j.fct.2009.10.048.View ArticlePubMed
- Ravi K, Rajasekaran S, Subramanian S: Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats. Food Chem Toxicol. 2005, 43: 1433-1439. 10.1016/j.fct.2005.04.004.View ArticlePubMed
- Sharma SB, Balomajumder C, Roy P: Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats. Food Chem Toxicol. 2008, 46: 2376-2383. 10.1016/j.fct.2008.03.020.View ArticlePubMed
- Betterridge J: Lipid disorders in diabetes mellitus. Textbook of Diabetes. Edited by: Pickup J, Williams G. 2002, London: Blackwell Science, 551-553.
- Yadav JP, Sushila S, Kalia AN, Dangi AS: Hypoglycemic and hypolipidemic activity of ethanolic extract of Salvadora oleoides in normal and alloxan-induced diabetic rats. Indian J Pharmacol. 2008, 40: 23-27. 10.4103/0253-7613.40485.PubMed CentralView ArticlePubMed
- Sharma SB, Nasir A, Prabhu KM, Murthy PS, Dev G: Hypoglycaemic and hypolipidemic effect of ethanolic extract of seeds of Eugenia jambolana in alloxan-induced diabetic rabbits. J Ethnopharmacol. 2003, 85: 201-206. 10.1016/S0378-8741(02)00366-5.View ArticlePubMed
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/264/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.